Skip Navigation


Carcinogenesis Advance Access originally published online on August 4, 2005
Carcinogenesis 2006 27(1):64-72; doi:10.1093/carcin/bgi201
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
27/1/64    most recent
bgi201v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hellerbrand, C.
Right arrow Articles by Bosserhoff, A.-K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hellerbrand, C.
Right arrow Articles by Bosserhoff, A.-K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis vol.27 no.1 © Oxford University Press 2005; all rights reserved.

Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma

Claus Hellerbrand *, Marcus Mühlbauer, Susanne Wallner 1, Marion Schuierer 1, Iris Behrmann 2, Frauke Bataille 1, Thomas Weiss 3, Jürgen Schölmerich and Anja-Katrin Bosserhoff 1

Department of Internal Medicine I and 1 Institute of Pathology, University of Regensburg, D-93042 Regensburg, Germany, 2 Institute of Biochemistry, RWTH-Aachen, D-52074 Aachen, Germany and 3 Department of Surgery, University of Regensburg, D-93042 Regensburg, Germany

* To whom correspondence should be addressed. Tel: +49 941 944 7104; Fax: +49 941 944 7002; Email: claus.hellerbrand{at}klinik.uni-regensburg.de

The methylthioadenosine phosphorylase (MTAP) gene is localized in the chromosomal region 9p21. Here, frequently homozygous deletions occur in several kinds of cancer associated with the loss of tumour suppressor genes as p16 and p15. The aim of this study was to analyse MTAP expression in hepatocellular carcinoma (HCC) and to get an insight into the regulation and functional role of MTAP in hepatocancerogenesis. Compared with primary human hepatocytes MTAP expression was markedly downregulated in three different HCC cell lines as determined by real-time PCR and western blotting. This was not due to genomic losses or mutations but to promoter-hypermethylation. Reduced MTAP-expression was confirmed in vivo in HCC compared with non-cancerous liver tissue on both mRNA and protein levels. To study the functional relevance of the downregulated MTAP expression in HCC, MTAP expression was re-induced in HCC cell lines by stable transfection. In these MTAP re-expressing cell clones the invasive potential was strongly reduced, whereas no effects on cell proliferation were observed in comparison with mock transfected cell clones. Furthermore, in MTAP re-expressing cells interferon (IFN)-{alpha} and IFN-{gamma} induced a significantly stronger inhibition of cell proliferation than in mock transfected cells. In conclusion, our results suggest a functional role of MTAP inactivation in HCC development and invasiveness. Furthermore, in the light of a recent report revealing an association between MTAP activity and IFN sensitivity, our findings may have clinical significance for therapeutic strategies.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
H.-Y. Huang, S.-H. Li, S.-C. Yu, F.-F. Chou, C.-C. Tzeng, T.-H. Hu, Y.-H. Uen, Y.-F. Tian, Y.-H. Wang, F.-M. Fang, et al.
Homozygous Deletion of MTAP Gene as a Poor Prognosticator in Gastrointestinal Stromal Tumors
Clin. Cancer Res., November 15, 2009; 15(22): 6963 - 6972.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. Amann, U. Maegdefrau, A. Hartmann, A. Agaimy, J. Marienhagen, T. S. Weiss, O. Stoeltzing, C. Warnecke, J. Scholmerich, P. J. Oefner, et al.
GLUT1 Expression Is Increased in Hepatocellular Carcinoma and Promotes Tumorigenesis
Am. J. Pathol., April 1, 2009; 174(4): 1544 - 1552.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
C Hellerbrand, T Amann, J Schlegel, P Wild, F Bataille, T Spruss, A Hartmann, and A-K Bosserhoff
The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma
Gut, February 1, 2008; 57(2): 243 - 251.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Marce, O. Balague, L. Colomo, A. Martinez, S. Holler, N. Villamor, F. Bosch, G. Ott, A. Rosenwald, L. Leoni, et al.
Lack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: implications for a potential targeted therapy.
Clin. Cancer Res., June 15, 2006; 12(12): 3754 - 3761.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.